Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs TrueMe

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and TrueMe head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 134 · Grade C

TrueMe

Visit TrueMe Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 72 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make TrueMe a bad call — it's best for readers in a listed state who want to compare a single month with a prepaid term. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
46
Supply Reliability
95
85
Transparency
90
94
Access Breadth
93
62
Clinical Oversight
92
78
Track Record
88
74
CoreAge RxBrief Score 94 · 72TrueMe

Price, coverage & the tracker

CoreAge RxTrueMe
Brief Score94/100 (A)72/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$139/mo or $267 upfront for three months of compounded semaglutide.

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$149/mo or $297 upfront for three months of compounded tirzepatide.

CoverageUS only; restrictions by state, confirmed at intakeTrueMe lists Arizona, Colorado, Missouri, Pennsylvania, Texas and Wisconsin.
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

TrueMe: Compare the full prepaid charge with the monthly plan.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.